JOURNAL OF HYPERTENSION高血压杂志

JOURNAL OF HYPERTENSION(英文缩写 J HYPERTENS),ISSN 0263-6352,eISSN 1473-5598,中文译名:高血压杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
5.600
JCR 分区
Q1
CAS 分区
B3
近一年发文量
288
本站 PubMed 收录统计

发文量统计区间:2025-09-27 至 2026-09-27,按本站收录文献的发表日期统计。

ISSN: 0263-6352 · eISSN: 1473-5598 · 缩写: J HYPERTENS ·中文: 高血压杂志

期刊介绍

选择期刊介绍栏目

期刊简介

《Journal of Hypertension》是高血压领域的国际性同行评议期刊,涵盖基础、临床与公共卫生研究。内容涉及血压调节机制、心血管风险、靶器官损害、降压治疗及流行病学,读者包括内科医师、心血管研究者、肾脏病专家和公共卫生人员。该刊注重将实验发现与临床实践衔接,为高血压防治提供循证依据。

研究方向

主要方向包括高血压发病机制、血管生物学、肾素-血管紧张素系统、血压测量与监测、降压药物临床试验、代谢与心血管风险因素、靶器官损伤及人群血压管理。论文类型以原创研究、系统综述、荟萃分析和指南共识为主,也刊载短篇报告与评论。

期刊特色

研究取向兼顾机制探索与临床转化,强调研究设计严谨、数据充分和结论稳健。论文通常要求明确的临床或生物学意义,适合从事高血压、心血管、肾脏及内分泌研究的学者和临床医生阅读与投稿,对跨学科血压管理议题亦有覆盖。

投稿难度

投稿难度中等偏上,期刊对创新性、方法学质量和临床相关性要求较高。建议准备时突出研究问题的新意,完善统计分析与样本量说明,并清晰阐述对高血压防治的潜在影响;若被拒稿,可根据审稿意见补充机制或亚组分析后改投。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
20214.776Q2
20224.900Q2
20233.300Q1
20244.100Q1
20255.600Q1

JOURNAL OF HYPERTENSION 最新收录文献

  1. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    1. Professor John Low Reid, OBE, DM, FRCP, FRSE, FMedSci.

    作者:
    Anna F Dominiczak, Matthew R Walters, Anthony Michael Heagerty, George F Stergiou, Ian Wilkinson, Christian Delles
    日期:
    2026-10-01

    该文献暂无摘要。

  2. JCR分区: Q1 CAS分区: B3 影响因子: 5.6
  3. JCR分区: Q1 CAS分区: B3 影响因子: 5.6
  4. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    4. Emergency department blood pressure elevations frequently occur without documented hypertension diagnosis.

    4. 急诊科血压升高常发生于未记录高血压诊断的情况下
    作者:
    Diane Kuhn, Paul I Musey, Katherine A Pollard, Grant A Parrelli, Phillip Levy
    日期:
    2026-10-01

    High blood pressure readings (HBPRs) are common in emergency department (ED) patients, but the frequency of HBPRs among patients without a documented diagnosis of hypertension (DDxHTN) is unclear. We performed a retrospective study of discharged ED encounters at a large Midwestern academic ED in 2024. HBPRs were defined as blood pressure ≥130 mmHg systolic or ≥80 mmHg diastolic. Among 66 624 discharged encounters with blood pressure data, 52 461 (78.7%) had at least one HBPR and 38 715 (58.1%) had at least one Stage 2-range HBPR (≥140/90 mmHg). Among patients with Stage 2-range HBPRs, 22 471 (58.0%) lacked DDxHTN. Older age, female sex, Black race, absence of interpreter need, and Medicare or Medicaid coverage were independently associated with DDxHTN. More than half of discharged ED patients with Stage 2-range HBPRs lacked DDxHTN, and many had only a single documented blood pressure. The ED may provide an opportunity for blood pressure reassessment and outpatient referral.

  5. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    5. Blood pressure phenotypes and hypertension-associated cardiac damage.

    作者:
    Maria Randjelovic, Magnus Wijkman, Karin Festin, Lisa Kastbom, David Kylhammar, Fredrik H Nyström, Carl Johan Östgren
    日期:
    2026-10-01

    The aim of this study was to characterize hypertension-associated cardiac damage in the blood pressure (BP) phenotypes sustained normotension (SNT), white coat hypertension (WCHT), masked hypertension (MHT) and sustained hypertension (SHT). In a population-based study, 4115 individuals were examined with office and home BP measurement, computed tomography, coronary computed tomography angiography and echocardiography. The odds ratios of hypertension-associated cardiac damage in the BP phenotypes were analysed with SNT and SHT as references, respectively, for coronary artery calcium score (CACS) at least 100 and at least 300, Segment Involvement Score (SIS) at least 4, any significant (>50%) coronary stenosis, left ventricular ejection fraction (LVEF) less than 50%, E/e΄ ratio (E/e΄) at least 14, and global longitudinal strain (GLS) greater than -17 (men) or greater than -18 (women). The odds of having hypertension-associated cardiac damage were significantly higher for WCHT than for SNT [LVEF < 50%: OR 1.83 (1.17-2.86), CACS ≥ 100: OR 1.58 (1.19-2.11)], and for SHT than for SNT [LVEF < 50%: OR 2.34 (1.53-3.57), CACS ≥ 100: OR 1.52 (1.14-2.02)]. The odds of having hypertension-associated cardiac damage were also significantly higher for MHT than for SNT (LVEF < 50%: OR 2.68 (1.41-5.10), CACS ≥ 100: OR 2.15 (1.37-3.38) and CACS ≥ 300: OR 2.34 (2.21-4.52)]. The prevalence of hypertension-associated cardiac damage was higher in WCHT and in MHT compared to SNT. WCHT and MHT should therefore be considered when assessing cardiovascular risk, and BP should be measured both in the office and at home when diagnosing and monitoring hypertension.

  6. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    6. A modified model of cardiac reverse remodeling following abdominal aortic banding and debanding in rats.

    作者:
    Shukun He, Yanting Zhang, Jiawei Shi, Jingrong Jiang, Tianshu Liu, Wenhui Deng, Wenqu Li, Ying Bai, Jiani Qiu, Yingxin Li, Qiaofeng Jin, Phil Chowienczyk, Li Zhang, Mingxing Xie, Haotian Gu, Jing Wang
    日期:
    2026-10-01

    Cardiac reverse remodeling (RR) after pressure unloading has been widely studied using abdominal aortic banding (AB) and debanding (DB) models. However, the DB procedure is technically challenging and associated with high postoperative mortality, limiting broader use. Here, we aim to develop a modified, film-supported ligature technique for AB and DB to improve procedural feasibility and survival and to generate a reproducible RR model. A rat cardiac RR model was established using medical film-supported abdominal AB followed by DB. Rats underwent 4 weeks of AB and then 2 weeks of DB. Echocardiography and blood pressure measurement were performed to confirm successful establishment of pressure overload and subsequent unloading. RR was assessed by echocardiographic structural and functional parameters, cardiac histology and serum levels of BNP, ANP and GDF-15. The modified DB procedure yielded a postoperative survival rate of 93.33%. AB induced significant hemodynamic changes at the constriction site and led to progressive cardiac remodeling and diastolic dysfunction from 4 to 6 weeks. After 2 weeks of DB, cardiac function showed substantial improvement; serum BNP, ANP and GDF-15 levels, as well as cardiac hypertrophy and fibrosis returned close to baseline. The film-supported AB and DB model is a technically streamlined and reproducible rat approach that markedly reduces postoperative mortality and enables consistent induction and reversal of cardiac remodeling. This model provides a useful experimental platform for studies of RR.

  7. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    7. Nighttime blood pressure versus non-dipping for predicting asymptomatic organ damage in young individuals.

    作者:
    Aikaterini Theodosiadi, Anastasios Kollias, Emelina Stambolliu, Angeliki Ntineri, Antonios Destounis, Ariadni Menti, Maria-Elena Zeniodi, George Servos, Andriani Vazeou, George S Stergiou
    日期:
    2026-10-01

    Circadian blood pressure (BP) phenotypes are associated with cardiovascular risk, though understudied in youth. This study in young individuals investigated the association of nighttime BP with measures of hypertension mediated organ damage (HMOD), primary endpoint of interest in this low absolute cardiovascular risk population. Individuals aged 6-25 years were evaluated with 24-h ambulatory BP monitoring (ABPM). HMOD investigation included echocardiographic left ventricular mass index (LVMI) and ultrasonographic common carotid artery intima-media thickness (IMT). Two hundred and seventy-six individuals were included (mean age 13.8 ± 3.8 years, 67% males) with ABPM data (23.6% ABPM hypertension, 26.4% nighttime hypertension, 30.4% non-dippers) and LVMI (n = 257) and/or IMT (n = 205). BP and HMOD indices increased with age, whereas non-dipping prevalence was not associated with age. Non-dippers vs. dippers had higher LVMI (30.5 ± 8.2 vs. 28.4 ± 5.95 g/m2.7, P = 0.01) and IMT (0.52 ± 0.05 vs. 0.50 ± 0.05 mm, P = 0.02), adjusted for age, sex, body mass index z-score (BMIz) and 24-h systolic BP (SBP). Individuals with nighttime hypertension vs. nighttime normotension had higher LVMI (32.76 ± 8.02 vs. 27.69 ± 5.65 g/m2.7, P < 0.001) and a trend towards higher IMT (0.52 ± 0.06 vs. 0.50 ± 0.05 mm, P = 0.16), adjusted for age, sex and BMIz. Dippers and non-dippers with nighttime hypertension had higher LVMI than dippers with nighttime normotension (all P < 0.05). In multivariable models, non-dipping independently associated with LVMI/ IMT (β = -2.14/-0.02, all P < 0.05), after adjustment for 24-h SBP, but not for nighttime SBP (β = -0.9/-0.01, for LVMI/IMT, respectively, all P = NS). In young individuals asymptomatic HMOD is associated with both nocturnal hypertension and non-dipping. However, nighttime BP levels seem to have the primary contributing role.

  8. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    8. Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.

    作者:
    George S Stergiou, Ariadni Menti, Kei Asayama, Anastasios Kollias, Gianfranco Parati, Aletta E Schutte, Jiguang Wang, Dagnovar Aristizabal, Roland Asmar, Grzegorz Bilo, Tomas Bothe, Christopher Clark, Kazuomi Kario, Yan Li, Richard McManus, Takayoshi Ohkubo, Paolo Palatini, Dean Picone, Daichi Shimbo, Thomas Tsaganos, Alejandro De La Sierra
    日期:
    2026-10-01

    Wearable wristwatch-type cuff oscillometric blood pressure (BP) monitors represent a new category of BP devices and are the first wearable monitors to use established cuff-oscillometric BP measurement technology. This consensus statement by the European Society of Hypertension Working Group on BP Monitoring reviews the published evidence on their design, accuracy, validation, clinical application, and remaining research questions. Of 281 articles identified through a systematic PubMed search, 26 were relevant. Several devices are currently available; however, only two have published validation studies performed according to established standards (Omron HeartGuide and Huawei Watch D/D2). Static validation studies generally showed acceptable accuracy, whereas data on 24-h ambulatory use, in special populations, and clinical applications remain limited. Potential advantages include self-initiated measurement at home, at work, and in other settings and conditions; more convenient and repeatable 24-h ambulatory monitoring; more convenient and accurate assessment of asleep BP; capture of stress-related and other BP-related episodes. However, proper wrist position, user adherence, ambulatory performance, and clinical applications require further investigation. More research is needed to establish the accuracy and clinical utility of these novel devices and their role in improving the diagnosis and management of hypertension.

  9. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    9. Theoretical foundations of bloodletting therapy for primary hypertension in the southern school of Tibetan medicine: insights from Qinghai-Tibet Plateau medical theory.

    作者:
    Wujin Danzeng, Ciwang Duoji, Gama Gele, Ga Wu
    日期:
    2026-10-01

    Primary hypertension (PH) remains a significant contributor to global morbidity and mortality. While contemporary biomedical treatments are widely utilized, traditional medical systems such as Tibetan medicine provide distinctive diagnostic frameworks and therapeutic modalities. Among these, venesection therapy constitutes a key external intervention, frequently employed in managing conditions corresponding to PH, referred to in classical texts as Trak lung tö tsang (khrag rlung stod 'tshangs, blood-wind proliferation). This narrative review synthesizes evidence from classical Tibetan medical literature and modern clinical and experimental studies, without a systematic search of primary biomedical literature. This study conducts a comprehensive review of classical Tibetan medical literature to elucidate the theoretical origins of venesection therapy as practiced in the southern school of Tibetan medicine, with a particular focus on its application for Trak lung tö tsang (khrag rlung stod 'tshangs, blood-wind proliferation). Additionally, the analysis explores potential theoretical convergence between traditional concepts and current biomedical understandings of hypertension pathophysiology. Clarifying the theoretical underpinnings and scientific relevance of this traditional therapy may contribute to integrative approaches for managing PH, as well as to the scientific validation and the preservation of traditional Tibetan medical practices. This review also aims to inform the development of complementary and alternative therapeutic strategies for the broader management of PH.

  10. JCR分区: Q1 CAS分区: B3 影响因子: 5.6

    10. Efficacy and safety of selective aldosterone synthase inhibitors for blood pressure reduction in patients with CKD: a meta-analysis of randomized controlled trials.

    作者:
    Marieta Theodorakopoulou, Fotini Iatridi, Aikaterini Theodosiadi, Manfred Hecking, Giovanni Strippoli, Pantelis Sarafidis
    日期:
    2026-10-01

    Aldosterone synthase inhibitors (ASIs) demonstrated significant blood pressure (BP) lowering efficacy in patients with uncontrolled hypertension, but evidence in chronic kidney disease (CKD) remains limited. This meta-analysis explores the effects of selective ASIs on BP levels in CKD. Secondary outcomes were albuminuria (UACR), eGFR change and hyperkalemia incidence. Five RCTs (1,148 patients) were included; 2 used baxdrostat, 2 lorundrostat, and 1 study used vicadrostat. Treatment with ASIs was associated with a significant placebo-adjusted reduction in SBP of-7.9 mmHg [95% confidence interval (CI) -10.0 to -5.9, I2 = 0%] and DBP of -3.1 mmHg (95% CI -5.9 to -0.2, I2 = 62%) and reduced UACR by -31.7% (95% CI -54.5 to -8.9, I2 = 91%). The pooled placebo-adjusted eGFR change was -2.05 ml/min/1.73 m 2 (95% CI -3.15 to -0.95, I2 = 0%). The risk of hyperkalemia was higher with ASIs, but with high heterogeneity (risk ratio, 4.04 [95% CI 0.94 to 17.35], I2 = 76%). In conclusion, selective ASIs present a potential treatment option for BP control and albuminuria reduction in patients with CKD.

在 JOURNAL OF HYPERTENSION 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊